MediBic Alliance Invests In Strand Genomics
10/19/2005 5:11:24 PM
Strand Genomics, leading Bangalore-based Life Sciences Informatics company today announced that MediBic Alliance, the investment arm of MediBic of Japan, has taken a minority equity stake in Strand. The Series A investment was closed in September 2002 by lead investor WestBridge Capital Partners and UTI Ventures, who continue to remain active on the board. MediBic and Strand are already in a long-term business partnership to jointly develop and market informatics solutions to pharmaceutical customers in Japan. MediBic will be represented on the Board of Directors of Strand Genomics with immediate effect.
comments powered by